These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33183580)

  • 1. Lipid nanoparticles coated with chitosan using a one-step association method to target rifampicin to alveolar macrophages.
    Vieira ACC; Chaves LL; Pinheiro M; Lima SC; Neto PJR; Ferreira D; Sarmento B; Reis S
    Carbohydr Polym; 2021 Jan; 252():116978. PubMed ID: 33183580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucoadhesive chitosan-coated solid lipid nanoparticles for better management of tuberculosis.
    Vieira ACC; Chaves LL; Pinheiro S; Pinto S; Pinheiro M; Lima SC; Ferreira D; Sarmento B; Reis S
    Int J Pharm; 2018 Jan; 536(1):478-485. PubMed ID: 29203137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis.
    Chokshi NV; Khatri HN; Patel MM
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1975-1989. PubMed ID: 30058392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promising Chitosan-Coated Alginate-Tween 80 Nanoparticles as Rifampicin Coadministered Ascorbic Acid Delivery Carrier Against Mycobacterium tuberculosis.
    Scolari IR; Páez PL; Sánchez-Borzone ME; Granero GE
    AAPS PharmSciTech; 2019 Jan; 20(2):67. PubMed ID: 30627867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Novel Octanoyl Chitosan Nanoparticles for Improved Rifampicin Pulmonary Delivery: Optimization by Factorial Design.
    Petkar KC; Chavhan S; Kunda N; Saleem I; Somavarapu S; Taylor KMG; Sawant KK
    AAPS PharmSciTech; 2018 May; 19(4):1758-1772. PubMed ID: 29589222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan-coupled solid lipid nanoparticles: Tuning nanostructure and mucoadhesion.
    Sandri G; Motta S; Bonferoni MC; Brocca P; Rossi S; Ferrari F; Rondelli V; Cantù L; Caramella C; Del Favero E
    Eur J Pharm Biopharm; 2017 Jan; 110():13-18. PubMed ID: 27989765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mannosylated solid lipid nanoparticles for the selective delivery of rifampicin to macrophages.
    Vieira ACC; Chaves LL; Pinheiro M; Lima SAC; Ferreira D; Sarmento B; Reis S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):653-663. PubMed ID: 29433346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-formulation of rifampicin with enhanced bioavailability: development, characterization and in-vivo safety.
    Singh H; Jindal S; Singh M; Sharma G; Kaur IP
    Int J Pharm; 2015 May; 485(1-2):138-51. PubMed ID: 25769294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical Characterization of Chitosan-Decorated Finasteride Solid Lipid Nanoparticles for Skin Drug Delivery.
    Sohaib M; Shah SU; Shah KU; Shah KU; Khan NR; Irfan MM; Niazi ZR; Alqahtani AA; Alasiri A; Walbi IA; Mahmood S
    Biomed Res Int; 2022; 2022():7792180. PubMed ID: 35971450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery.
    Song X; Lin Q; Guo L; Fu Y; Han J; Ke H; Sun X; Gong T; Zhang Z
    Pharm Res; 2015 May; 32(5):1741-51. PubMed ID: 25407545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and evaluation of metformin-loaded solid lipid nanoparticles for celluar and mitochondrial uptake.
    Xu Q; Zhu T; Yi C; Shen Q
    Drug Dev Ind Pharm; 2016; 42(5):701-6. PubMed ID: 26288997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan-Coated Solid Lipid Nanoparticles as an Efficient Avenue for Boosted Biological Activities of
    Aldayel TS; M Badran M; H Alomrani A; AlFaris NA; Z Altamimi J; S Alqahtani A; A Nasr F; Ghaffar S; Orfali R
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110803
    [No Abstract]   [Full Text] [Related]  

  • 13. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel.
    Shi LL; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR
    Drug Dev Ind Pharm; 2017 May; 43(5):839-846. PubMed ID: 27487431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis.
    Rawal T; Parmar R; Tyagi RK; Butani S
    Colloids Surf B Biointerfaces; 2017 Jun; 154():321-330. PubMed ID: 28363192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation of acyclovir-loaded solid lipid nanoparticles: 2. Brain targeting and pharmacokinetic study.
    El-Gizawy SA; El-Maghraby GM; Hedaya AA
    Pharm Dev Technol; 2019 Dec; 24(10):1299-1307. PubMed ID: 31507245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium Acetate Coated Tenofovir-Loaded Chitosan Nanoparticles for Improved Physico-Chemical Properties.
    Ngo AN; Ezoulin MJ; Murowchick JB; Gounev AD; Youan BB
    Pharm Res; 2016 Feb; 33(2):367-83. PubMed ID: 26553351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid Lipid Nanoparticles and Chitosan-coated Solid Lipid Nanoparticles as Promising Tool for Silybin Delivery: Formulation, Characterization, and In vitro Evaluation.
    Piazzini V; Cinci L; D'Ambrosio M; Luceri C; Bilia AR; Bergonzi MC
    Curr Drug Deliv; 2019; 16(2):142-152. PubMed ID: 30306869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting.
    Nimje N; Agarwal A; Saraogi GK; Lariya N; Rai G; Agrawal H; Agrawal GP
    J Drug Target; 2009 Dec; 17(10):777-87. PubMed ID: 19938949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted macrophages delivery of rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment.
    Vieira AC; Magalhães J; Rocha S; Cardoso MS; Santos SG; Borges M; Pinheiro M; Reis S
    Nanomedicine (Lond); 2017 Dec; 12(24):2721-2736. PubMed ID: 29119867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, optimization, and
    Nasiri F; Faghfouri L; Hamidi M
    Drug Dev Ind Pharm; 2020 Jan; 46(1):159-171. PubMed ID: 31894713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.